This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Worcester Polytechnic Institute. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of Katie Flynn: Advancing Stem Cell Research
Introduction
Katie Flynn, an innovative inventor located in Pawtucket, Rhode Island, is making significant strides in scientific research with her groundbreaking patent in stem cell technology. With a strong focus on enhancing the effectiveness of human mesenchymal stem cells (hMSCs), her work is poised to have important implications for regenerative medicine.
Latest Patents
Katie Flynn holds a patent for a "Nanofibrous scaffold comprising immobilized cells," which addresses the challenge of stem cell migration from their delivery site. This invention is particularly notable for allowing hMSCs to communicate effectively with native cardiomyocytes while preventing unwanted migration. The device features a two-part polyurethane scaffold, specifically designed with optimized pore sizes and fiber diameters to facilitate gap junction formation through its pores, ensuring a minimally invasive delivery method of stem cell therapy.
Career Highlights
Katie is affiliated with Worcester Polytechnic Institute, where she has been able to collaborate with leading researchers in the field. Her dedication to advancing stem cell research and her innovative approach to solving complex biomedical problems spotlight her as a rising talent in the scientific community.
Collaborations
In her professional journey, Katie Flynn has had the opportunity to work alongside esteemed colleagues such as Glenn R. Gaudette and Matthew D. Phaneuf. Their collaboration reflects a multidisciplinary approach that enhances the potential impact of their research on stem cell applications and regeneration therapies.
Conclusion
Katie Flynn's contributions to the field of stem cell research through her innovative patent and collaborative efforts highlight her as a key inventor in advancing medical technology. Her work not only showcases the potential of hMSCs in regenerative medicine but also sets a benchmark for future innovations in the field. As she continues to develop her research, the implications of her inventions may lead to significant advancements in how we approach stem cell therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile